D. Oulid-Aïssa

489 total citations
7 papers, 397 citations indexed

About

D. Oulid-Aïssa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D. Oulid-Aïssa has authored 7 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in D. Oulid-Aïssa's work include Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). D. Oulid-Aïssa is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). D. Oulid-Aïssa collaborates with scholars based in France, Switzerland and Denmark. D. Oulid-Aïssa's co-authors include Egbert F. Smit, Giuseppe Giaccone, Mariëlle Gallegos Ruiz, Thierry Le Chevalier, Jean‐Charles Soria, Nick Thatcher, Pasi A. Jänne, José Antonio Rodríguez, G Lagrue and Éric Pujade-Lauraine and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Cancer Research.

In The Last Decade

D. Oulid-Aïssa

7 papers receiving 374 citations

Peers

Countries citing papers authored by D. Oulid-Aïssa

Since Specialization

Citations

This map shows the geographic impact of D. Oulid-Aïssa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Oulid-Aïssa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Oulid-Aïssa more than expected).

Fields of papers citing papers by D. Oulid-Aïssa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Oulid-Aïssa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Oulid-Aïssa. The network helps show where D. Oulid-Aïssa may publish in the future.

Co-authorship network of co-authors of D. Oulid-Aïssa

This figure shows the co-authorship network connecting the top 25 collaborators of D. Oulid-Aïssa. A scholar is included among the top collaborators of D. Oulid-Aïssa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Oulid-Aïssa. D. Oulid-Aïssa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study 2006 ·Clinical Cancer Research ·Giuseppe Giaccone, Mariëlle Gallegos Ruiz, Thierry Le Chevalier, Nick Thatcher, Egbert F. Smit, José Antonio Rodríguez, Pasi A. Jänne, D. Oulid-Aïssa, Jean‐Charles Soria	164
2	A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer 2005 ·Journal of Clinical Oncology ·Giuseppe Giaccone, T. Lechevalier, Nicholas Thatcher, Egbert F. Smit, Maarten L. Janmaat, J. Rodríguez, D. Oulid-Aïssa, J.C. Soria	25
3	Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer 2002 ·Annals of Oncology ·Bengt Glimelius, Raija Ristamäki, Michael Kjær, Per Pfeiffer, Torben Skovsgaard, Kjell M. Tveit, Thomas Linné, Jan‐Erik Frödin, (unknown), D. Oulid-Aïssa, Seppo Pyrhönen	31
4	CPT-11 combined or alternated with 5 fluoruracil/folinic acid (5-FU/FA) vs mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC) 2001 ·Gastroenterology ·Ullrich Graeven, Karsten Ridwelski, M.P. Manns, Juergen Schöelmerich, Pilar España, A Murias, Göran Carlsson, Markus Borner, D. Oulid-Aïssa, (unknown), W Schmiegel	1
5	A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck 1999 ·British Journal of Cancer ·C. Couteau, Nadia Chouaki, Serge Leyvraz, D. Oulid-Aïssa, (unknown), C. Domenge, (unknown), (unknown), François Janot, M Forni, (unknown)	69
6	The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication 1997 ·British Journal of Clinical Pharmacology ·A Béhar, Éric Pujade-Lauraine, (unknown), Michèle Brun, G Lagrue, (unknown), D. Oulid-Aïssa, Darcy A. Hille	58
7	Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation 1995 ·Cancer Chemotherapy and Pharmacology ·(unknown), René Bruno, Valérie Cosson, J. Vergniol, D. Oulid-Aïssa, M. Marty, M. Clavel, Matti Aapro, N Le Bail, Athanassios Iliadis	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact